Prestige Consumer Healthcare, Inc. (PBH)
47.20
+0.76
(+1.64%)
USD |
NYSE |
May 20, 16:00
47.20
0.00 (0.00%)
After-Hours: 18:04
Prestige Consumer Healthcare Cash from Investing (Quarterly) : -3.414M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -3.916B |
| Amneal Pharmaceuticals, Inc. | -21.71M |
| Crinetics Pharmaceuticals, Inc. | -252.36M |
| Corcept Therapeutics, Inc. | 4.542M |
| Assertio Holdings, Inc. | 15.11M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 42.84M |
| Cash from Financing (Quarterly) | -38.10M |
| Free Cash Flow | 246.45M |
| Free Cash Flow Per Share (Quarterly) | 0.7891 |
| Free Cash Flow to Equity (Quarterly) | 71.49M |
| Free Cash Flow to Firm (Quarterly) | 47.15M |
| Free Cash Flow Yield | 10.72% |